CorMedix Inc (NASDAQ: CRMD) is 43.88% higher on its value in year-to-date trading and has touched a low of $2.57 and a high of $7.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CRMD stock was last observed hovering at around $5.70 in the last trading session, with the day’s loss setting it -0.29%.
Currently trading at $5.41, the stock is -2.01% and 17.53% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.89 million and changing -5.17% at the moment leaves the stock 40.90% off its SMA200. CRMD registered 3.05% gain for a year compared to 6-month gain of 53.26%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 2.46% loss in the last 1 month and extending the period to 3 months gives it a 79.14%, and is 0.74% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.38% over the week and 8.87% over the month.
CorMedix Inc (CRMD) has around 82 employees, a market worth around $297.44M and $0.00M in sales. Distance from 52-week low is 110.51% and -22.71% from its 52-week high. The company has generated returns on investments over the last 12 months (-65.58%).
The EPS is expected to grow by 17.73% this year
The shares outstanding are 54.94M, and float is at 53.94M with Short Float at 17.38%.
CorMedix Inc (CRMD) Insider Activity
The most recent transaction is an insider purchase by Todisco Joseph, the company’s Chief Executive Officer. SEC filings show that Todisco Joseph bought 13,561 shares of the company’s common stock on Mar 13 ’24 at a price of $3.74 per share for a total of $50718.0. Following the purchase, the insider now owns 0.35 million shares.
CorMedix Inc disclosed in a document filed with the SEC on Dec 15 ’23 that DUNTON ALAN W (Director) bought a total of 3,000 shares of the company’s common stock. The trade occurred on Dec 15 ’23 and was made at $3.30 per share for $9900.0. Following the transaction, the insider now directly holds 15250.0 shares of the CRMD stock.
Still, SEC filings show that on Dec 14 ’23, DUNTON ALAN W (Director) acquired 3,000 shares at an average price of $3.45 for $10350.0. The insider now directly holds 12,250 shares of CorMedix Inc (CRMD).
